在多发性骨髓瘤中,ERBB2/HER2的高调表达是不良生存结果的预测因素
1Immuno-Oncology Program, Ares Pharmaceuticals, St. Paul, MN 55110, USA.
International journal of molecular sciences
|June 28, 2023
概括
在多发性骨髓瘤 (MM) 血细胞中的高ERBB2/HER2mRNA表达表明预后不佳. 这一发现表明,ERBB2向可能改善MM患者的治疗结果,特别是那些患有高风险或耐药性疾病的患者.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 多发性骨髓瘤 (MM) 是血细胞的癌症.
- ERBB2/HER2是一种受体氨酸激酶,与各种癌症有关.
- 在MM中ERBB2/HER2的预后作用尚不清楚.
研究的目的:
- 研究基于RNA测序 (RNAseq) 的ERBB2/HER2表达在MM患者恶性血细胞中的临床意义.
- 确定ERBB2/HER2mRNA水平与患者生存结果之间的关联.
主要方法:
- 用RNA测序 (RNAseq) 来量化787名MM患者恶性血细胞中的ERBB2/HER2mRNA水平.
- 在ERBB2/HER2mRNA水平和生存结果 (无进展生存,整体生存) 之间进行了相关性分析.
- 采用多变量考克斯比例危险模型,以调整其他预后因素.
主要成果:
- 与ERBB1和ERBB3.3相比,ERBB2/HER2mRNA在MM细胞中显著上调.
- 较高的ERBB2/HER2mRNA水平与调节ERBB2/HER2.2的转录因子的表达增加相关.
- 增加ERBB2/HER2mRNA表达与MM患者的无进展生存率和整体生存率明显恶化有关.
- 高ERBB2/HER2表达的不良预后影响在多变量分析中仍然显著.
结论:
- 恶性血细胞中的高ERBB2/HER2mRNA表达是多发性骨髓瘤中一种新的不良预后标志物.
- 这些发现支持进一步研究ERBB2/HER2的预后价值以及ERBB2/HER2向疗法的潜力,以针对高风险或耐火性MM的个性化治疗.
关键词:
欧洲农业基金 (EGF) 提供.在ERBB1中,它是ERBB1.在ERBB2中,它是ERBB2.在HER2中,HER2是HER2.多发性骨髓瘤是多发性骨髓瘤的一种.蛋白质铁氨酸激酶酶是一种蛋白质.转录因子的转录因子更多相关视频
08:28Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
195
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.5K
相关概念视频
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
